Literature DB >> 25776844

Heterozygosity for the common perforin mutation, p.A91V, impairs the cytotoxicity of primary natural killer cells from healthy individuals.

Imran G House1, Kevin Thia2, Amelia J Brennan2, Richard Tothill3, Alexander Dobrovic4, Wei Z Yeh2, Richard Saffery5, Zac Chatterton5, Joseph A Trapani6, Ilia Voskoboinik7.   

Abstract

The production and delivery of functional perforin (PRF; PRF1 gene) by cytotoxic lymphocytes maintains immune homeostasis and tumour immune surveillance. In humans, inheritance of the common PRF1 polymorphism, p.A91V, (c.272C>T) found in 8-9% of the Caucasian population, with another mutated allele resulting in reduced PRF function or trafficking, has been shown to result in hyperinflammatory diseases and/or haematological cancers. In this study, we sought to investigate the function of p.A91V on a wild-type (WT) perforin background. We first developed an assay that distinguishes the relative levels of transcription of individual PRF1 alleles, including p.A91V. The p.A91V allele was seen to be expressed at similar levels as the WT allele in primary human natural killer (NK) cells, ruling out that allelic expression imbalance influenced their function. We then demonstrated that the p.A91V mutation results in protein misfolding and an appreciable reduction in NK-cell cytotoxicity in healthy carriers of p.A91V. We propose that this level of cytotoxic dysfunction may readily account for the predisposition to immune-mediated disease in individuals homozygous for p.A91V. Also, the fact that monoallelic mutations of PRF1 decrease NK-cell cytotoxicity should be considered in individuals presenting with the manifestations of immune deficiency states that impinge on NK-cell cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25776844     DOI: 10.1038/icb.2015.1

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  24 in total

1.  Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function.

Authors:  Ilia Voskoboinik; Vivien R Sutton; Annette Ciccone; Colin M House; Jenny Chia; Phillip K Darcy; Hideo Yagita; Joseph A Trapani
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

2.  Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack.

Authors:  Jamie A Lopez; Olivia Susanto; Misty R Jenkins; Natalya Lukoyanova; Vivien R Sutton; Ruby H P Law; Angus Johnston; Catherina H Bird; Phillip I Bird; James C Whisstock; Joseph A Trapani; Helen R Saibil; Ilia Voskoboinik
Journal:  Blood       Date:  2013-02-01       Impact factor: 22.113

3.  A single amino acid change A91V in perforin: a novel, frequent predisposing factor to childhood acute lymphoblastic leukemia?

Authors:  Alessandra Santoro; Sonia Cannella; Antonino Trizzino; Luca Lo Nigro; Giovanni Corsello; Maurizio Aricò
Journal:  Haematologica       Date:  2005-05       Impact factor: 9.941

4.  A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin.

Authors:  Christina Trambas; Federico Gallo; Daniela Pende; Stefania Marcenaro; Lorenzo Moretta; Carmela De Fusco; Alessandra Santoro; Luigi Notarangelo; Maurizio Arico; Gillian M Griffiths
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113

5.  A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis.

Authors:  Ilia Voskoboinik; Marie-Claude Thia; Joseph A Trapani
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

6.  Association between granzyme B and perforin I polymorphisms and allograft outcomes in Hispanic kidney transplant recipients.

Authors:  Eglis Corrales-Tellez; Don Vu; Tariq Shah; Ian Hutchinson; David I Min
Journal:  Clin Transplant       Date:  2013-03-26       Impact factor: 2.863

7.  Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer.

Authors:  Jenny Chia; Kim Pin Yeo; James C Whisstock; Michelle A Dunstone; Joseph A Trapani; Ilia Voskoboinik
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-01       Impact factor: 11.205

Review 8.  Perforin deficiency and susceptibility to cancer.

Authors:  A J Brennan; J Chia; J A Trapani; I Voskoboinik
Journal:  Cell Death Differ       Date:  2010-01-15       Impact factor: 15.828

9.  Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice.

Authors:  D Kägi; B Odermatt; P Seiler; R M Zinkernagel; T W Mak; H Hengartner
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

10.  Human perforin mutations and susceptibility to multiple primary cancers.

Authors:  Joseph A Trapani; Kevin Y T Thia; Miles Andrews; Ian D Davis; Craig Gedye; Philip Parente; Suzanne Svobodova; Jenny Chia; Kylie Browne; Ian G Campbell; Wayne A Phillips; Ilia Voskoboinik; Jonathan S Cebon
Journal:  Oncoimmunology       Date:  2013-04-01       Impact factor: 8.110

View more
  21 in total

1.  Functional and genetic testing in adults with HLH reveals an inflammatory profile rather than a cytotoxicity defect.

Authors:  Julien Carvelli; Christelle Piperoglou; Catherine Farnarier; Frédéric Vely; Karin Mazodier; Sandra Audonnet; Patrick Nitschke; Christine Bole-Feysot; Mohamed Boucekine; Audrey Cambon; Mohamed Hamidou; Jean-Robert Harle; Geneviève de Saint Basile; Gilles Kaplanski
Journal:  Blood       Date:  2020-07-30       Impact factor: 22.113

Review 2.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

3.  Late relapse of primary hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation: a consequence of low-level chimerism from a carrier donor?

Authors:  Amy E Verrinder; Joanna L S Marsden; Mary A Slatter; Leigh McDonald; Chris M Bacon; Joaquim Majo; Andrew R Gennery
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

4.  A rapid turnaround gene panel for severe autoinflammation: Genetic results within 48 hours.

Authors:  Dara McCreary; Ebun Omoyinmi; Ying Hong; Barbara Jensen; Alice Burleigh; Fiona Price-Kuehne; Kimberly Gilmour; Despina Eleftheriou; Paul Brogan
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

5.  Lymphoma as an Exclusion Criteria for CVID Diagnosis Revisited.

Authors:  Vincent Allain; Virginie Grandin; Véronique Meignin; Rémi Bertinchamp; David Boutboul; Claire Fieschi; Lionel Galicier; Laurence Gérard; Marion Malphettes; Jacinta Bustamante; Mathieu Fusaro; Nathalie Lambert; Jérémie Rosain; Christelle Lenoir; Sven Kracker; Frédéric Rieux-Laucat; Sylvain Latour; Jean-Pierre de Villartay; Capucine Picard; Eric Oksenhendler
Journal:  J Clin Immunol       Date:  2022-09-26       Impact factor: 8.542

Review 6.  The genetics of macrophage activation syndrome.

Authors:  Grant S Schulert; Randy Q Cron
Journal:  Genes Immun       Date:  2020-04-15       Impact factor: 2.676

7.  Missense mutations in the perforin (PRF1) gene as a cause of hereditary cancer predisposition.

Authors:  Mohammed S Chaudhry; Kimberly C Gilmour; Imran G House; Mark Layton; Nicki Panoskaltsis; Mamta Sohal; Joseph A Trapani; Ilia Voskoboinik
Journal:  Oncoimmunology       Date:  2016-06-02       Impact factor: 8.110

8.  Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza.

Authors:  Grant S Schulert; Mingce Zhang; Ndate Fall; Ammar Husami; Diane Kissell; Andrew Hanosh; Kejian Zhang; Kristina Davis; Jeffrey M Jentzen; Lena Napolitano; Javed Siddiqui; Lauren B Smith; Paul W Harms; Alexei A Grom; Randy Q Cron
Journal:  J Infect Dis       Date:  2015-11-23       Impact factor: 5.226

9.  Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis.

Authors:  Ebun Omoyinmi; Ariane Standing; Annette Keylock; Fiona Price-Kuehne; Sonia Melo Gomes; Dorota Rowczenio; Sira Nanthapisal; Thomas Cullup; Rodney Nyanhete; Emma Ashton; Claire Murphy; Megan Clarke; Helena Ahlfors; Lucy Jenkins; Kimberly Gilmour; Despina Eleftheriou; Helen J Lachmann; Philip N Hawkins; Nigel Klein; Paul A Brogan
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

10.  Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption.

Authors:  Robin C Willenbring; Fang Jin; David J Hinton; Mike Hansen; Doo-Sup Choi; Kevin D Pavelko; Aaron J Johnson
Journal:  J Neuroinflammation       Date:  2016-08-31       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.